Helen Jenkins

Dr Helen Jenkins is a Partner at Oxera Consulting LLP, where she has more than 25 years of professional experience applying economics to strategic business issues, particularly litigation and competition investigations. Oxera describes her sector experience as spanning energy, financial services, retailing, communications, media, pharmaceuticals, digital, life sciences, and postal/logistics markets.

Jenkins joined Oxera in 1993. After Oxera’s 2003 management buy-out, she became one of two Managing Directors alongside Dr Luis Correia da Silva. In December 2016, following Oxera’s conversion to LLP status in 2014, she became Oxera’s first Managing Partner, a role created to lead the partnership in delivering the firm’s strategic objectives while she continued client advisory and expert work. Dr Gunnar Niels succeeded her as Managing Partner in January 2022 after her five-year term.

Her expert and advisory work includes matters for Mastercard International, Microsoft, National Grid, Royal Mail, Intercontinental Exchange, the Commonwealth of Australia, Ryanair, Pfizer, Standard Life Aberdeen, BritNed, and the Hong Kong Competition Commission. She has been listed in The International Who’s Who of Competition Lawyers & Economists since 2001 and in WWL Thought Leaders Global Elite - Competition Economists since 2021.

Jenkins holds a DPhil and MPhil in Economics from the University of Oxford, and a BEc (Hons) in Science and Economics from the Australian National University in Canberra. She is also an author of *Economics for Competition Lawyers*, whose third edition was published by Oxford University Press in 2023.

• No verified public source reviewed identifies Helen Jenkins as an active angel investor, seed investor, or venture investor, and no verified check size or startup investment thesis was found.
• Her verified professional focus is economic analysis for competition, litigation, regulation, damages, collective actions, commercial disputes, and arbitration.
• Her sector focus, per Oxera, includes digital, energy, financial services, pharmaceuticals and life sciences, and postal/logistics.
• For venture-adjacent topics, she hosted Oxera’s February 2026 *Top of the Agenda* episode on venture capital with Tim Jenkinson and Francis Woolley, discussing how venture capital works, its risks, and its role in innovation and productivity.
• Her publicly stated client orientation as Managing Partner was to help clients “navigate an ever-changing global economy.”